(Q37909189)

25 August 2017

1 reference

title

The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review (English)

1 reference

25 August 2017

1 reference

3

Orlando Santana

1 reference

25 August 2017

Christos G Mihos

1

1 reference

25 August 2017

Rosa T Artola

series ordinal

2

1 reference

25 August 2017

publication date

31 July 2011

1 reference

Rheumatology International

25 August 2017

published in

1 reference

25 August 2017

volume

32

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

287-294

1 reference

Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Beyond lipid lowering: the role of statins in vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Inhibition of protein geranylgeranylation induces apoptosis in synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Persistence with Statins and Onset of Rheumatoid Arthritis: A Population-Based Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Effects of statins on bone mineral density: a meta-analysis of clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Synergistic Effect of Statins and Postmenopausal Hormone Therapy in the Prevention of Skeletal Fractures in Elderly Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Effect of combining ACE inhibitor and statin in lupus-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Avascular necrosis prevention with lipitor in lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Statins as immunomodulators in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Potential benefit of statins for vascular disease in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Protein geranylgeranylation controls collagenase expression in osteoarthritic cartilage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Simvastatin induces apoptosis of fibroblast-like synoviocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Statins for the treatment of antiphospholipid syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Effects of HMG-CoA reductase inhibitors on continuous post-inflammatory vascular remodeling late after Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Effects of statin therapy in children complicated with coronary arterial abnormality late after Kawasaki disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Statin therapy might be beneficial for patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Behçet's disease complicated by IgA nephropathy with nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Therapy-refractory systemic juvenile idiopathic arthritis successfully treated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Current overview of statin-induced myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

ANCA-positive vasculitis associated with simvastatin/ezetimibe: expanding the spectrum of statin-induced autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

A case of ANCA-associated systemic vasculitis induced by atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Cerivastatin-induced polymyalgia rheumatica-like illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Statins and “Chameleon-Like” Cutaneous Eruptions: Simvastatin-Induced Acral Cutaneous Vesiculobullous and Pustular Eruption in a 70-Year-Old Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2008-6

Atorvastatin and BMD in coronary syndrome. Role of Lys656Asn polymorphism of leptin receptor gene

21 January 2018

1 reference

12 December 2020

Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial

1 reference

12 December 2020

Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort.

1 reference

12 December 2020

High concentration simvastatin induces apoptosis in fibroblast-like synoviocytes from patients with rheumatoid arthritis.

1 reference

12 December 2020

Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study

1 reference

12 December 2020

Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers

1 reference

12 December 2020

Protective effect of atorvastatin in cultured osteoarthritic chondrocytes.

1 reference

12 December 2020

Lipid composition of the tissues of human knee joints. I. Observations in normal joints (articular cartilage, meniscus, ligaments, synovial fluid, synovium, intra-articular fat pad and bone marrow)

1 reference

12 December 2020

Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

1 reference

12 December 2020

Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density

1 reference

12 December 2020

Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production

1 reference

12 December 2020

The remarkable beneficial effect of adding oral simvastatin to topical betamethasone for treatment of psoriasis: a double-blind, randomized, placebo-controlled study.

1 reference

12 December 2020

Lupus Atherosclerosis Prevention Study (LAPS)

1 reference

12 December 2020

Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis

1 reference

12 December 2020

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

12 December 2020

Statins and dietary fish oils improve lipid composition in bone marrow and joints

1 reference

12 December 2020

1 reference

12 December 2020

Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients.

1 reference

12 December 2020

RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin

1 reference

12 December 2020

Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin

1 reference

12 December 2020

Possibilities of atorvastatin in complex management of extensive psoriasis in patients with arterial hypertension

1 reference

12 December 2020

Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARγ2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures

1 reference

12 December 2020

Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome

1 reference

12 December 2020

Fluvastatin improves osteoporosis in fructose-fed insulin resistant model rats through blockade of the classical mevalonate pathway and antioxidant action

1 reference

12 December 2020

Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis.

1 reference

12 December 2020

Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome.

1 reference

12 December 2020

HMG-CoA reductase inhibitor simvastatin suppresses Toll-like receptor 2 ligand-induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients

1 reference

12 December 2020

Locally applied simvastatin promotes fracture healing in ovariectomized rat

1 reference

12 December 2020

Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis

1 reference

12 December 2020

Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis.

1 reference

12 December 2020

[Progress of research in osteoarthritis. The anti-inflammatory effects of intra-articular injected statin on experimental osteoarthritis]

1 reference

12 December 2020

10.1007/S00296-011-2008-6

Identifiers

DOI

1 reference

25 August 2017

1 reference